Sepsis

H2HUBB PLAIN-LANGUAGE TAKEAWAY The study adds to the molecular-hydrogen evidence base, but the available record does not support a firm conclusion about therapeutic benefit. Molecular hydrogen sepsis study 23057: what the findings mean This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. The publication “Sepsis” was classified as […]

Read More

The epidemiology of sepsis in the United States from 1979 through 2000.

H2HUBB PLAIN-LANGUAGE TAKEAWAY The study adds to the molecular-hydrogen evidence base, but the available record does not support a firm conclusion about therapeutic benefit. Molecular hydrogen sepsis study: what the findings mean This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. The publication “The epidemiology of sepsis in […]

Read More

Molecular Hydrogen Reverses Sepsis-induced Immunoparalysis: Insights from Longitudinal Deep Immunophenotyping.

In this case report, adjunctive hydrogen inhalation was followed by temporary clinical stabilization and longitudinal immune changes in a 49-year-old man with refractory septic shock. The report described the patient's death from irreversible chronic comorbidities. This single case suggests possible immunomodulatory potential, while controlled clinical studies are needed to determine safety and effectiveness.

Read More